Macular Edema With Central Retinal Vein Occlusions
Also known as: Central Retinal Vein Occlusion With Macular Edema / Central retinal vein occlusion with macular edema (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB08885 | Aflibercept | A vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy, and metastatic colorectal cancer |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB08885 | Aflibercept | Vascular endothelial growth factor A | target |
DB08885 | Aflibercept | Placenta growth factor | target |
DB08885 | Aflibercept | Vascular endothelial growth factor B | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08885 | Aflibercept | 1 / 2 | Completed | 1 |
DB01270 | Ranibizumab | 3 | Recruiting | 1 |
DB08885 | Aflibercept | 4 | Completed | 1 |
DB11077 | Polyethylene glycol 400 | 4 | Completed | 1 |
DB01839 | Propylene glycol | 4 | Completed | 1 |
DB01270 | Ranibizumab | 4 | Unknown Status | 1 |
DB08885 | Aflibercept | Not Available | Completed | 1 |